Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 21;12:680211. doi: 10.3389/fneur.2021.680211

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Daibert-Nido, Pyatova, Cheung, Nayomi, Markowitz, Bouffet and Reber.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Case 1—Visual outcome measures. (A) Contrast sensitivity at baseline (gray line) and at the end of the treatment (week 7—black line) in the left (OS) and the right (OD) eye. (B) Esterman binocular field test post-treatment (week 7). Red squares indicate newly acquired points, black circles indicate lost points, compared to baseline. (C) Monocular Humphrey full-field test (81 points) post-treatment (week 7) in the left (OS) and right (OD) eye. Red squares indicate newly acquired points, and black circles indicate lost points, compared to baseline. (D) Reading speed at baseline, week 3, and post-treatment (week 7). (E) Quality of life scores at baseline, week 3, and post-treatment (week 7). Gray shaded areas in (A,D,E) indicate the values of the coefficient of repeatability (±COR). OD, oculus dexter; OS, oculus sinister; W, week.